SCHEMBL3175889

SCHEMBL3175889

CC(=O)NCCNc1nc(-c2ccccc2)nc(NCCNC(=O)c2cccc(C)c2)c1C

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 1/20 0.58
ADORA1 P30542 1/20 0.58
ALDH1A1 P00352 6/20 0.57
KDM4E B2RXH2 3/20 0.57
SMN1; SMN2 Q16637 2/20 0.57
NPC1 O15118 1/20 0.52
RAB9A P51151 1/20 0.52
LMNA P02545 2/20 0.52
CYP1A2 P05177 7/20 0.52
CYP3A4 P08684 7/20 0.52
CYP2D6 P10635 6/20 0.52
CLK4 Q9HAZ1 6/20 0.52
TSHR P16473 3/20 0.52
CYP2C19 P33261 3/20 0.52
MEN1 O00255 1/20 0.51
KMT2A Q03164 1/20 0.51
USP2 O75604 2/20 0.51
MAPT P10636 3/20 0.49
HSD17B10 Q99714 2/20 0.49
RECQL P46063 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3165096 0.91 ADORA2A (0.65) ADORA2AADORA1ALDH1A1KDM4ELMNA
SCHEMBL3172187 0.91 ALDH1A1 (0.54) ADORA2AADORA1ALDH1A1KDM4ESMN1; SMN2
SCHEMBL3177178 0.89 ADORA2A (0.56) ADORA2AADORA1ALDH1A1KDM4ESMN1; SMN2
SCHEMBL3174346 0.88 NPC1 (0.53) ADORA2AADORA1ALDH1A1KDM4ESMN1; SMN2
SCHEMBL3172990 0.88 ADORA2A (0.61) ADORA2AADORA1ALDH1A1KDM4ESMN1; SMN2
SCHEMBL3162050 0.87 ADORA2A (0.72) ADORA2AADORA1ALDH1A1KDM4ELMNA
SCHEMBL3172317 0.87 ADORA2A (0.53) ADORA2AADORA1ALDH1A1KDM4ELMNA
SCHEMBL3256770 0.87 CYP1A2 (0.67) ADORA2AADORA1ALDH1A1KDM4ESMN1; SMN2
SCHEMBL3171963 0.87 ADORA2A (0.60) ADORA2AADORA1ALDH1A1KDM4ESMN1; SMN2
SCHEMBL3156465 0.85 ADORA2A (0.61) ADORA2AADORA1ALDH1A1KDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1465631-B1 PYRIMIDINE A2B SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE OSI PHARM INC (US) 2010-02-24 EP disclosed